- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants
-
- Jared Pitts
- Gilead Sciences, Inc., Foster City, California, USA
-
- Jiani Li
- Gilead Sciences, Inc., Foster City, California, USA
-
- Jason K. Perry
- Gilead Sciences, Inc., Foster City, California, USA
-
- Venice Du Pont
- Gilead Sciences, Inc., Foster City, California, USA
-
- Nicholas Riola
- Gilead Sciences, Inc., Foster City, California, USA
-
- Lauren Rodriguez
- Gilead Sciences, Inc., Foster City, California, USA
-
- Xianghan Lu
- Gilead Sciences, Inc., Foster City, California, USA
-
- Chaitanya Kurhade
- Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA
-
- Xuping Xie
- Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA
-
- Gregory Camus
- Gilead Sciences, Inc., Foster City, California, USA
-
- Savrina Manhas
- Gilead Sciences, Inc., Foster City, California, USA
-
- Ross Martin
- Gilead Sciences, Inc., Foster City, California, USA
-
- Pei-Yong Shi
- Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA
-
- Tomas Cihlar
- Gilead Sciences, Inc., Foster City, California, USA
-
- Danielle P. Porter
- Gilead Sciences, Inc., Foster City, California, USA
-
- Hongmei Mo
- Gilead Sciences, Inc., Foster City, California, USA
-
- Evguenia Maiorova
- Gilead Sciences, Inc., Foster City, California, USA
-
- John P. Bilello
- Gilead Sciences, Inc., Foster City, California, USA
Search this article
Description
<jats:p>Genetic variation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in the emergence and rapid spread of multiple variants throughout the pandemic, of which Omicron is currently the predominant variant circulating worldwide. SARS-CoV-2 variants of concern/variants of interest (VOC/VOI) have evidence of increased viral transmission, disease severity, or decreased effectiveness of vaccines and neutralizing antibodies.</jats:p>
Journal
-
- Antimicrobial Agents and Chemotherapy
-
Antimicrobial Agents and Chemotherapy 66 (6), e0022222-, 2022-06-21
American Society for Microbiology
- Tweet
Details 詳細情報について
-
- CRID
- 1360021394460626560
-
- ISSN
- 10986596
- 00664804
-
- Data Source
-
- Crossref
